Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.75.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KT.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
LE.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
JN.1.7.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
JN.1.49.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.3.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
JN.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
GE.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-17071Singapore
BA.5.2.20SYoung-STATACATGTCTCTGGGACCA20452176321782F29.6049Singapore
BQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
DV.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.4.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.75SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
CH.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BF.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
CH.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.7.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
CH.1.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BM.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.4.6.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.12.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
LZ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used